Arbutus Biopharma Corp (ABUS)

Cash & Short-Term Investments

$92.63M

Quarterly · Period ending: · USD

ABUS logo

ABUS Cash & Short-Term Investments

Latest reported$92.63M
ABUS Quarterly Cash & Short-Term Investments ($21.08M → $92.63M)
High-resolution chart · PNG

ABUS cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arbutus Biopharma Corp Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
92,625,000
95,226,000
91,471,000
93,702,000
98,088,000
112,707,000
122,623,000
127,794,000
141,986,000
129,240,000
126,003,000
134,180,000
152,484,000
146,728,000
146,913,000
134,718,000
150,199,000
165,477,000
155,317,000
121,403,000
78,379,000
131,961,000
123,268,000
118,296,000
82,388,000
84,891,000
90,834,000
90,082,000
95,282,000
110,590,000
124,617,000
142,018,000
154,869,000
172,540,000
126,352,000
88,179,000
103,009,000
110,379,000
130,559,000
149,682,000
165,310,000
172,574,000
181,304,000
196,095,000
207,200,000
232,276,000
112,161,000
108,757,000
117,233,000
134,357,000
68,716,531
35,788,859
38,716,548
43,058,551
47,028,656
5,723,029
6,821,087
8,765,146
8,995,234
8,880,455
10,027,278
9,495,390
12,344,034
15,409,119
17,253,811
18,175,666
23,300,296
25,186,835
24,493,256
23,798,111
26,252,135
32,304,205
37,214,580
19,399,411
21,130,481
21,117,071
21,079,752
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.